Ronald L. Gibson, Jr., M.D., Ph.D.
CURRICULUM VITAE
Ronald L. Gibson, Jr., M.D., Ph.D. March 2009
1. Personal Data
Born:September 2, 1954
Seattle, Washington
Married:Maren Holmquist Gibson on June 5, 1976
Children:Kali Alexandra Gibson (1/17/1984)
Bryn Maren Gibson (1/7/1987)
2. Education
Undergraduate:1972-75University of Washington, Seattle, Washington - Major field of Biology, B.S.
Graduate:1976-82Washington University Schools of Medicine and Arts & Sciences, St. Louis, Missouri - M.D. and Ph.D.
Doctoral Thesis: The role of oligosaccharide chains in the maturation and physical properties of the G protein of vesicular stomatitis virus
3. Postgraduate Training
Internship:1982-83 Pediatrics, University of WashingtonSchool of Medicine, Seattle, Washington
Residency:1983-85 Pediatrics, University of WashingtonSchool of Medicine, Seattle, Washington
1985 Assistant Chief Pediatric Resident, University of
WashingtonSchool of Medicine, Seattle, Washington
Fellowship:1985-88Pediatric Pulmonology, Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington
4. Faculty Positions Held
1988-1994Assistant Professor, Department of Pediatrics, University of WashingtonSchool of Medicine, Seattle, Washington
1991-1997Research Affiliate, Child Development and Mental RetardationCenter, University of Washington, Seattle, Washington
1994-2003Associate Professor, Department of Pediatrics, University of WashingtonSchool of Medicine, Seattle, Washington
2003-presentProfessor, Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington
5. Hospital Positions Held
1988-presentAttending Physician, Seattle Children's Hospital, Seattle, Washington
1988-presentConsultant, University of Washington Medical Center, Seattle, Washington
1994-99Consultant, SwedishHospital & MedicalCenter Special Care Nursery, Seattle, Washington
6. Honors and Awards
1975 B.S. summa cum laude in Biology, University of Washington
1975 Phi Beta Kappa, University of Washington, Seattle, Washington
1976-82 Medical Scientist Training Grant from the National Institutes of Health, Washington University School of Medicine, St. Louis, Missouri
1977 Richard S. Brookings Medical Prize, WashingtonUniversitySchool of Medicine, St. Louis, Missouri
1982 Alexander Berg Prize in Microbiology, WashingtonUniversitySchool of Medicine, St. Louis, Missouri
1982 Alpha Omega Alpha (AOA), WashingtonUniversitySchool of Medicine, St. Louis, Missouri
1991 Outstanding Teacher Award, University of WashingtonSchool of Medicine, Pediatric Residency Training Program
1997Stanley Stamm Role Model Award in Medicine (for conscientious teaching and patient care), University of Washington School of Medicine, Pediatric Residency Training Program
1997Society for Pediatric Research, Elected Member
1999Outstanding Teacher Award, University of WashingtonSchool of Medicine, Pediatric Residency Training Program
2000Family Choice Award from the Parent Advisory Council at Children’s Hospital & Regional Medical Center (CHRMC), Seattle, WA
2000Voted one of Seattle’s Top Doctors per Seattle Magazine poll of peers
2001Nominee, Family Choice Award from Parent Advisory Council at CHRMC
2002 Nominee, Family Choice Award from Parent Advisory Council at CHRMC
2004Outstanding Teacher Award, University of WashingtonSchool of Medicine, Pediatric Residency Training Program
2005Voted one of Seattle’s Top Doctors per Seattle Magazine poll of peers
2005Nominee, Family Choice Award from Family Advisory Council at CHRMC
2005Selected to the Best Doctors in America
2006Voted one of Seattle’s Top Doctors per Seattle Magazine poll of peers
2007Voted one of Seattle’s Top Doctors per Seattle Magazine poll of peers
2007-08Selected to Best Doctors in America
2008Mentoring Award from the University of Washington School of Medicine, Department of Pediatrics (recognizes outstanding mentoring of junior faculty)
2008Voted one of Seattle’s Top Doctors per Seattle Magazine poll of peers
Grants/Research Awards
1985-1990National Institutes of Health, Program Project (PI, W.A. Hodson):
Neonatal Pulmonary Circulation: Co-Investigator (R. Gibson)
1987 Research Training Fellowship, American Lung Association, 1987-88
1987 Research Grant, American Lung Association: The Specificity and
Bacterial Stimulus of Pulmonary Hypertension in Neonatal Sepsis
1988 Research Training Fellowship, American Lung Association, 1988-89
1988-91 RJR Nabisco Research Scholar Award: Bacterial-Host Cell
Interactions that Stimulate Proinflammatory Mediators in
Neonatal Group B Streptococcal Sepsis
1990-95Maternal Child Health, Pediatric Pulmonary Center Training Grant
(P.I.: G. Redding, Co-I: R. Gibson)
1991-93 Research Grant, WashingtonTechnologyCenter: The Role of
Pulmonary Microvascular Endothelial Cell Response in Lung Disease
1991-94Edward Livingston Trudeau Scholar Award, American Lung
Association: Group B Streptococcus Endothelial Cell Interactions
1993-98Co-PIs (B. Ramsey, R. Gibson)/Mentors of Leroy Matthews
Physician Scientist Award
1995-2000Maternal Child Health, Pediatric Pulmonary Center Training Grant
(P.I.: G. Redding, Co-I: R. Gibson)
1996-97Cystic Fibrosis Foundation Grant
Gene Therapy in the Developing Airways of Mice
1996-97Cystic Fibrosis-Research Development Program Pilot Grant
1998-Cystic Fibrosis Clinical CareCenter Grant (PI, R. Gibson)
1998-2003Cystic Fibrosis Foundation Therapeutics Development Center
(Co-PIs R. Gibson/Moira Aitken)
1999-Director of the Clinical Core, CFF- Research Development Program
2000-2005Maternal Child Health, Pediatric Pulmonary Center Training Grant
(P.I.: G. Redding, Co-I: R. Gibson)
1999-2002Food and Drug Administration Orphan Product Development Grant
TOBI in Young Children with Cystic Fibrosis (Co-PI, R. Gibson)
2000-2005National Institutes of Health: Inhaled Tobramycin in Young Cystic Fibrosis Patients (#RO1 DK57755-01, PI-B. Ramsey, Co-PI R. Gibson)
2003-2008Cystic Fibrosis Foundation Therapeutics Development Center (Co-PIs R. Gibson/Moira Aitken, $500,000)
2003-2007Cystic Fibrosis Foundation Therapeutics: Standard vs. Biofilm
Susceptibility Testing in CF (PI: J. Burns/Moskowitz, Co-I: R. Gibson)
2004-2009Cystic Fibrosis Foundation Therapeutics: Early Pseudomonas
Infection Control (EPIC)-Observational Study
(PIs: M. Rosenfeld, R. Gibson)
2007-2009Cystic Fibrosis Foundation Therapeutics: Early Pseudomonas Infection Control (EPIC)-Observational Study- DNA Collection
Amendment (PI: R. Gibson)
2009-2014Cystic Fibrosis Foundation Therapeutics: Early Pseudomonas
Infection Control (EPIC)-Observational Study-Phase II
(PIs: M. Rosenfeld, R. Gibson)
2009-2014Cystic Fibrosis Foundation Translational TherapeuticsDevelopmentCenter
(Co-PIs: R Gibson, M. Aitken).
7. Board Certification
1982National Board of Medical Examiners
1988-Board Certified in Pediatrics (#36845)
1992-1999Board Certified in Pediatric Pulmonology (#303)
2000-2006Re-certified in Pediatric Pulmonology (PRCP-MS)
2007-2013Re-certified in Pediatric Pulmonology (PRCP-MS)
8. Current License to Practice
1983-presentWashington (# MD00021155)
9. Professional Organizations
National:
1986-88 AmericanAcademy of Pediatrics
1986-American Thoracic Society
1992-Pediatric Pulmonary Training Directors Association
1994-1998American Society for Microbiology
1997-Society for Pediatric Research
Local:
1989-Washington Thoracic Society
1990-Western Society for Pediatric Research
1990-Washington Chapter, AmericanAcademy of Pediatrics
10. Teaching Responsibilities
Medical Students- Interact with 2-3 medical students each week of inpatient service with daily case-based teaching in subspecialty rounds, or in weekly Chest/CF Clinic at CHRMC
Residents- Interact closely with 6 residents on the Pulmonary Team and 1-2 additional residents on the pulmonary elective for each week of subspecialty attending (10-12 weeks the past two years). These interactions include cased-based teaching at the bedside and in outpatient clinics, and 1-2 mini-lectures per week of attending.
Pediatric Pulmonology Fellows- co-Director of fellowship program with active role in recruitment, curriculum development, evaluation of trainees, and career counseling; Goal of one first-year fellow each year.
Graduates of our Pediatric Pulmonology Program (1992-2005):
Timothy D. Murphy, M.D.Associate Professor, Univ. of Pittsburgh Margaret Rosenfeld, M.D.,M.P.H. Associate Professor, Univ. of Washington
John P. Osborn, M.D. Clinical Assoc. Professor, Univ. of Virginia
Sonia K. Budhecha, M.D.Assistant Professor, Univ. of Nevada, Reno
Toby S. Lewis, M.D., M.P.H.Assistant Professor, University of Michigan
Samuel M. Moskowitz, M.D.Assistant Professor, Univ. of Washington
Jason S. Debley, M.D., M. P. H.Assistant Professor, Univ. of Washington
Martha McKinney, M.D., M.P.H.Asst. Prof., Queens Univ., Kingston, Ontario Lucas R. Hoffman, M.D., Ph.D. Assistant Professor, Univ. of Washington
Danny Hsia, MDOakland Children’s Hospital
DB Sanders, MD, MPHAsst. Prof, University of Wisconsin, Madison
11. Editorial Responsibilities: no editorial boards
12. Special National and Regional Committees/Activities
1992-Member, Pediatric Pulmonary Training Directors Association (PEPTDA)
1993Member, Committee to Review the Uniformed Services Pediatric Seminar Scientific Awards Competition for the Andrew Margileth Award
1995-Coordinator/Moderator for Regional, Quarterly CF Clinical Conferences including the University of Washington Adult Program, Spokane Affiliate Program, Tacoma Affiliate Program, Anchorage Affiliate Program, and Invitees from the University of Oregon and British Columbia
1997Site Visit to Affiliate CF Program in Spokane, WA
1998-2003Member, Steering Committee for the Cystic Fibrosis Therapeutic DevelopmentCenter Network
1998-Member, Pediatric Planning Committee for the Cystic Fibrosis Foundation (CFF) Therapeutic DevelopmentCenter Network (TDN)
1998Member, PEPTDA Workforce and Recruitment Subcommittee
1998Chairperson, Committee to develop Standard Operating Procedure for Spirometry within the Cystic Fibrosis Foundation Therapeutic Development Network (TDN)
1998Member, Committee to develop a Standard Operating Procedure for Nasal Potential Difference Measurements within the CFF TDN
1997Member, Data Safety Monitoring Committee for Intrabiotics-367 Multicenter Phase I Study
1998Speaker/Panelist at Roundtable Discussion on Guidelines for Assessing Affiliate CF Centers at the 1998 North American CF Foundation Meeting
1998Member, Committee to Review the Uniformed Services Pediatric Seminar Scientific Awards Competition for the Andrew Margileth Award
1999Site Visit to Affiliate CF Program in Anchorage, Alaska
1998Visiting Professor, University of California, San Diego, including Grand Rounds at Children’s Hospital, San Diego entitled “Cystic Fibrosis: Pathophysiology and Update on Treatment”
1999Invited Speaker for Post-Graduate Symposium on Aerosolized Antibiotics at the American Thoracic Society International Meeting
1999Roundtable Discussion Leader on Aerosolized Antibiotics in Cystic Fibrosis at the 1999 International North American Cystic Fibrosis Foundation Meeting
2000Site Visit to Affiliate CF Program in Spokane, WA
2000Chairperson, Committee on Early Interventions in Cystic Fibrosis, Northwest Cystic Fibrosis Consortium, Epidemiologic Study in Cystic Fibrosis (Genentech)
2000Invited to Cystic Fibrosis Foundation Williamsburg Conference
2000-Member, Cystic Fibrosis Foundation (CFF) Clinical Research Committee for National Review of Research Grants
2001Invited Speaker at American Thoracic Conference, “Impact of Early Antibiotic Treatment in Young Children with Cystic Fibrosis”
2001-Member, CFF-TDN Committee to Establish Quality Control Standards for Pulmonary Function Testing
2001Member, CFF-TDN Task Force for Re-Structuring of the Therapeutics Development Network
2002Member, Nominating Committee for Pediatric Pulmonary Training Directors Association Officers
2002-04Member, Steering Committee on Joint Project between the CFF and Proteome Systems (Australia)
2002Invited Speaker at the 2002 European CF Conference in Genoa, Italy, “Tobramycin Solution for Inhalation in Young Children with CF: Eradication of Lower Airway Pseudomonas”
2002-Member, Protocol Development Committee for the CF Therapeutics Development Network
2003Invited Speaker, “Pseudomonas Summit”, Cystic Fibrosis Foundation, Bethesda, MD
2004-2007Member, Steering Committee for the Cystic Fibrosis Therapeutic DevelopmentCenter Network
2004Invited Speaker at the 2004 European CF Conference in Birmingham, England
“Early Intervention Strategies in CF Lung Disease”
2004Member, National Committee to Develop Educational Slide Set on Early Intervention in Cystic Fibrosis
2004-Member, International CF Foundation Antimicrobial Task Force for Drug Development
2004-Member, Steering Committee, Early Pseudomonal Infection Control Study
2004-Chair, Publications & Presentations Committee, Early Pseudomonal Infection Control Study
2006Faculty for CF Foundation-sponsored national training course on GCP Clinical
Researchat 2006 North American CF Conference
2007-2008Selected Site in Cystic Fibrosis (CF) Foundation Leadership & Learning Collaborative V-National Continuous Quality Improvement Project to Improve Pulmonary Outcomes in CF
2007Co-Chairperson, Pseudomonas Workshop, Williamsburg Cystic Fibrosis Conference
2008Workshop Leader, International Consensus Conference on Pseudomonas Serology in CF, Bethesda, MD
13. Special Local Responsibilities/Committees
1988-University of Washington Pediatric Housestaff Selection-interviewer
1988-1990University of Washington Pediatric Intern Selection Committee
1989WAMI Visiting Professor, Sacred HeartMedicalCenter, Spokane, Washington
1989WAMI Visiting Professor, Yakima Pediatric Associates, Yakima, Washington
1990-2005Associate Director, Pediatric Pulmonary Center Training Grant (MCH #539167)
1990WAMI Visiting Professor, Yakima Pediatric Associates, Yakima, Washington
1991-2001Pharmacy and Therapeutics Committee, Children's Hospital & MedicalCenter, Seattle, Washington
1991Pediatric Grand Rounds at Children’s Hospital & RegionalMedicalCenter: Update on Bronchopulmonary Dysplasia
1991WAMI Visiting Professor, Yakima Pediatric Associates, Yakima, Washington
1992-Co-Director, Pediatric Pulmonary Fellowship Program, University of WashingtonSchool of Medicine, Seattle, Washington
1992-Co-Director, Pediatric Pulmonology Weekly Journal Club, Children's Hospital & RegionalMedicalCenter, Seattle, Washington
1992WAMI Visiting Professor, Yakima Pediatric Associates, Yakima, Washington
1993-5PMD Representative to Virginia Mason, South, Children's Hospital & MedicalCenter, Seattle, Washington
1993WAMI Visiting Professor, Yakima Pediatric Associates, Yakima, Washington
1994Chairman, Asthma Clinical Care Pathway, Children's Hospital & MedicalCenter, Seattle, Washington
1994WAMI Visiting Professor, Yakima Pediatric Associates, Yakima, Washington
1994-95POD C Outpatient Clinics Workgroup, Committee Member, Children's Hospital & Medical Center, Seattle, Washington
1995Pediatric Grand Rounds at Children’s Hospital & RegionalMedicalCenter: Review of Asthma Clinical Pathway
1995Speaker at Parent’s Day Educational Conference on Cystic Fibrosis
1995WAMI Visiting Professor, Yakima Pediatric Associates, Yakima, Washington and Toppenish Farm Workers Clinic/Providence Hospital, Toppenish, Washington
1996Chairman, Asthma Clinical Care Pathway Revision I, Children’s Hospital & Medical Center, Seattle, WA
1996Member, Laboratory Space Committee for the Department of Pediatrics, University of Washington School of Medicine, Seattle, WA
1996WAMI Visiting Professor, Yakima Pediatric Associates, Yakima, Washington and Toppenish Farm Workers Clinic/Providence Hospital, Toppenish, Washington
1996-1998Associate Director of the Cystic Fibrosis Center, Children’s Hospital & Medical Center, Seattle, Washington
1996-Member, Grand Rounds Steering Committee, Children’s Hospital & MedicalCenter, Seattle, WA
1996Member, Cardiovascular Surgery Quality Assurance Committee, Children’s Hospital & Medical Center, Seattle, WA
1997Asthma Managed Care Focus Group, Children’s Hospital and RegionalMedicalCenter, Seattle, WA
1999Chairperson, Asthma Clinical Pathway Revision II, Children’s Hospital & RegionalMedicalCenter, Seattle, WA
1997Member of Internal Review Committee for Child & Adolescent Psychiatry Training Program, University of Washington/CHRMC, Seattle, WA
1998Speaker at Parent’s Day Educational Conference on Cystic Fibrosis
1998Team Member for Care Coordination Pilot with Asthma Patients, CHRMC, Seattle, WA
1998Team Member for the Cystic Fibrosis Managed Care Readiness Project, CHRMC, Seattle, WA
1998Acting Director of the Cystic Fibrosis Center, CHRMC, Seattle, WA
1998-Center Director, Pediatric Program Director for the CysticFibrosisCenter, University of Washington, Children’s Hospital & RegionalMedicalCenter, Seattle, WA
1998-Director/Moderator of CF Center Quarterly Regional Conferences on Clinical Care- includes Pediatric CF Center at CHRMC, Adult CF Program at UWMC, Affiliate CF Programs at MaryBridge in Tacoma, WA, DeaconessHospital in Spokane, WA, and invitees from Kaiser in Portland, OR and CF Centers in Victoria and Vancouver, BC, Canada.
1998Chairperson, Cystic Fibrosis Clinical Pathway Revision Committee, CHRMC, Seattle, WA
1998-Local Spokesperson for Great Strides Fundraiser for Cystic Fibrosis
1999 Speaker at Parent’s Day Educational Conference on Cystic Fibrosis
1999Member, Asthma Clinical Pathway Revision Committee, CHRMC, Seattle, WA
1999CHRMC Quarterly Curbstone Consult: Chronic Cough (Editor, Dr. S. Dassel)
1999Chairperson, CHRMC Pharmacy & Therapeutics Subcommittee for Palivizumab
(Synagis) Guidelines
1999Speaker at 19th Annual F. Richard Dion Pediatric Update, Seattle, WA: Asthma
2000Speaker at Parent’s Day Educational Conference on Cystic Fibrosis
2000WWAMI Visiting Professor, Peninsula Children’s Clinic, Port Angeles, WA
2000CHRMC Quarterly Curbstone Consult: Asthma Pathway (Editor: Dr. S. Dassel)
2001Speaker at Parent Day Educational Conference on Cystic Fibrosis
2002Site Visit to Affiliate CF Center, Anchorage, Alaska
2002Invited Speaker at Puget Sound Allergy & Asthma Society Meeting: Update on the Diagnosis and Management of CF
2002Speaker at CF Regional Quarterly Conference: Macrolides and CF
2003Site Visit to Affiliate CF Center, Spokane, Washington
2003Speaker, CF Quarterly Regional Conference: Early Intervention for Pseudomonas in Children with CF
2004Member, Inpatient Medicine Project Subcommittee on Education
2004WWAMI Visiting Professor, Yakima Pediatric Associates, Yakima, WA and Toppenish Farm Workers Clinic/Providence Hospital, Toppenish, WA
2004Member, Cystic Fibrosis Research Faculty Search Committee, Department of Pediatrics/CHRMC (Chair: B. Ramsey)
2004Member, Neonatal Research Faculty Search Committee (Chair: D. Woodrum), Department of Pediatrics, University of WashingtonSchool of Medicine
2004Member, Institutional Review Board Forms Committee, CHRMC, Seattle, WA
2005Speaker at Parent’s Day Educational Conference on Cystic Fibrosis
2005Speaker at CF Quarterly Regional CF Conference: Hypertonic Saline in CF
2005-Director, Pediatric Pulmonary Fellowship Program, University of Washington School of Medicine, Seattle, Washington
2005-2007Member, Scholarship Oversight Committee for Pediatric Critical Care Fellow, Iain Asplin, MD, PhD
2006-Member, CUMG Physician Education, Billing, and Compliance Committee
2006-Member, Human Subject Protection Program Advisory Committee, CHRMC
2006WWAMI Visiting Professor, Pocatello Children & Adolescent Clinic, Pocatello, ID, and St. Luke’s Regional Medical Center, Boise, ID (3-day trip)
2006Panel Member, R2 Pediatric Retreat on Academic Career Options
2006Scientist/Poster Presenter at CHRMC Centennial Kick-off Research Event
2006-8Ad hoc member, Scholarship Oversight Committee, Danny Hsia, MD
2007Invited Speaker at 7th Annual Madigan Pediatric Update Conference: Update on the Treatment of CF Lung Disease.
2007Speaker at Parent’s Day Educational Conference on Cystic Fibrosis
2007-Member, Steering Committee, Center for Clinical and Translational Research, Seattle Children’s Hospital Research Institute
2007Presentation of the CHRMC Cystic FibrosisCenter Quality Improvement Program to the CHRMC Board
2007-9Ad hoc member, Scholarship Oversight Committee, DB Sanders, MD
2008WWAMI Visiting Professor, Peninsula Children’s Clinic, Port Angeles, WA
2008Participant in Medical Ward Team Configuration Meeting, CHRMC
2008Member, Review Committee for the Center for Clinical and Translational Research Mentored Scientist Program, Seattle Children’s Hospital
2008-Member, Recruitment Subcommittee for the Center for Clinical and Translational Research, Seattle Children’s Hospital
2008Case Presenter at Sconyers/Godfrey Ethics Grand Rounds, CHRMC
2008-Member, Appointments and Promotions Committee, Department of Pediatrics, University of Washington School of Medicine
2009Speaker, CF Parent Education Day
14. Research Funding
Name of Individual: Ronald L. Gibson, MD, PhD
ACTIVE(Renewable annually)
Project Number: C117-04Dates of Current Project: 7/1/08-6/30/09
Principal Investigator: Ronald L. Gibson, MD, PhDPercent Effort: 15%
Source: Cystic Fibrosis FoundationDirect Costs: $230,322
Title of Project: Cystic FibrosisCenter Grant
Major goals this project: Funding for ongoing support of the Cystic Fibrosis Clinical Center.
Name of Individual: Ronald L. Gibson, MD, PhD
ACTIVE
Project Number: GIBSON98Y0Dates of Entire Project: 4/1/09-3/31/14
Principal Investigator: Ronald L. Gibson, MD, PhDPercent Effort: 10%
Source: Cystic Fibrosis FoundationCurrent Direct Costs: $200,000
Title of Project: Translational Therapeutic DevelopmentCenter
Major goals of this project: To develop and conduct Phase I/II clinical trials in cystic fibrosis related research as part of the Cystic Fibrosis Foundation's Therapeutic Development Network.
Name of Individual: Ronald L. Gibson, MD, PhD
Role: Co-Investigator, Director of Clinical Core for Research Development ProgramACTIVE
Project Number: R565 Dates of Project: 10/1/08-9/30/09
Principal Investigator: E. Peter Greenberg, PhDPercent Effort: 5%
Source: Cystic Fibrosis FoundationDirect Costs: $42,000
Title of Project: Molecular Biology of Cystic Fibrosis: Clinical Core
Major goals of this project: To provide a national resource for development of well-designed clinical investigations in patients with CF and to foster collaboration with basic scientists to promote pilot studies by providing patient specimens or clinical data.
Name of Individual: Ronald L. Gibson, MD, PhD
Role: Co-Investigator
Project Number: BURN03A0Dates of Project: 6/1/04-12/31/07
Principal Investigator: Jane Burns, MDPercent Effort: 3%
Source: Cystic Fibrosis FoundationDirect Costs: $228,355
Title of Project: Standard versus Biofilm Susceptibility Testing in Cystic Fibrosis
Major goals of this project: To compare the microbiological efficacy, clinical efficacy, and safety of using standard versus biofilm susceptibility testing of P.aeruginosa sputum isolates to guide antibiotic selection of airway infection in clinically stable patients with CF.
Name of Individual: Ronald L. Gibson, MD, PhD
Role: Co-Principal Investigator
Dates of Project: 4/1/09-3/30/14Percent Effort: 15%
Source: Cystic Fibrosis FoundationDirect Costs: $1,328,747
Title of Project: EPIC Observational Study
Major goals of this project: A large, multicenter, prospective, descriptive study of the risk factors for and outcomes associated with initial acquisition of Pseudomonas aeruginosa as well as outcomes associated with therapy among CF patients 1 to 12 years of age.
GIBSON07K0 (Gibson – PI)9/1/07 – 8/31/09